Chimeric/JJ
oncoprotein/NN
E2a-Pbx1/NN
induces/VBZ
apoptosis/NN
of/IN
hematopoietic/JJ
cells/NNS
by/IN
a/DT
p53-independent/JJ
mechanism/NN
that/WDT
is/VBZ
suppressed/VBN
by/IN
Bcl-2/NN
./.

The/DT
chimeric/JJ
oncoprotein/NN
E2a-Pbx1/NN
results/VBZ
from/IN
fusion/NN
of/IN
the/DT
E2A/NN
and/CC
PBX1/NN
genes/NNS
following/VBG
t(1;19)/NN
chromosomal/JJ
translocations/NNS
in/IN
B/NN
cell/NN
precursor/NN
acute/JJ
leukemias/NNS
./.
=====
Experimentally/RB
B/NN
cell/NN
progenitors/NNS
do/VBP
not/RB
tolerate/VB
constitutive/JJ
expression/NN
of/IN
E2a-Pbx1/NN
which/WDT
contrasts/VBZ
with/IN
transformation/NN
of/IN
several/JJ
other/JJ
cell/NN
types/NNS
following/VBG
its/PRP$
stable/JJ
expression/NN
both/CC
in/FW
vitro/FW
and/CC
in/FW
vivo/FW
./.
=====
To/TO
further/RB
investigate/VB
the/DT
effects/NNS
of/IN
E2a-Pbx1/NN
on/IN
the/DT
B/NN
cell/NN
progenitors/NNS
,/,
we/PRP
conditionally/RB
expressed/VBD
E2a-Pbx1/NN
under/IN
control/NN
of/IN
a/DT
metal/JJ
response/NN
element/NN
in/IN
hematopoietic/JJ
precursor/NN
cell/NN
lines/NNS
in/FW
vitro/FW
./.
=====
Inducible/JJ
expression/NN
of/IN
E2a-Pbx1/NN
resulted/VBD
in/IN
cell/NN
death/NN
with/IN
the/DT
morphologic/JJ
and/CC
molecular/JJ
features/NNS
of/IN
apoptosis/NN
./.
=====
A/DT
structure-function/JJ
analysis/NN
demonstrated/VBD
that/IN
induction/NN
of/IN
apoptosis/NN
was/VBD
not/RB
a/DT
dominant-negative/JJ
effect/NN
of/IN
the/DT
E2a/NN
moiety/NN
but/CC
,/,
rather/RB
,/,
required/VBD
the/DT
DNA-binding/JJ
homeodomain/NN
of/IN
Pbx1/NN
./.
=====
E2a-Pbx1-induced/JJ
apoptosis/NN
proceeded/VBD
through/IN
a/DT
BCL2-responsive/JJ
checkpoint/NN
eventuating/NN
in/IN
PARP/NN
inactivation/NN
but/CC
did/VBD
require/VB
p53/NN
./.
=====
Constitutive/JJ
expression/NN
of/IN
E2a-Pbx1/NN
did/VBD
not/RB
induce/VB
apoptosis/NN
or/CC
continued/JJ
cycling/NN
of/IN
Rat-1/NN
fibroblasts/NNS
in/IN
low/JJ
serum/NN
conditions/NNS
./.
=====
These/DT
studies/NNS
demonstrate/VBP
that/IN
E2a-Pbx1/NN
initiates/VBZ
programmed/VBN
cell/NN
death/NN
of/IN
hematopoietic/JJ
precursers/NNS
by/IN
a/DT
mechanism/NN
that/WDT
requires/VBZ
its/PRP$
chimeric/JJ
transcriptional/JJ
properties/NNS
,/,
but/CC
,/,
unlike/IN
other/JJ
nuclear/JJ
oncoproteins/NNS
,/,
is/VBZ
independent/JJ
of/IN
p53/NN
./.